Your browser doesn't support javascript.
loading
Reply: Evaluation of the Inclisiran Safety in High-Risk Populations.
Wright, R Scott; Leiter, Lawrence A; Lesogor, Anastasia; Ray, Kausik K.
Affiliation
  • Wright RS; Mayo Clinic, Rochester, Minnesota, USA. Electronic address: wright.scott@mayo.edu.
  • Leiter LA; Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Lesogor A; Novartis Pharma AG, Basel, Switzerland.
  • Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Imperial College London, London, United Kingdom.
J Am Coll Cardiol ; 83(13): e129, 2024 Apr 02.
Article in En | MEDLINE | ID: mdl-38538207
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypercholesterolemia / Anticholesteremic Agents Limits: Humans Language: En Journal: J Am Coll Cardiol / J. Am. Coll. Cardiol / Journal of the American College of Cardiology Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypercholesterolemia / Anticholesteremic Agents Limits: Humans Language: En Journal: J Am Coll Cardiol / J. Am. Coll. Cardiol / Journal of the American College of Cardiology Year: 2024 Document type: Article Country of publication: